Literature DB >> 7778290

Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.

S Tugizov1, Y Wang, I Qadri, D Navarro, E Maidji, L Pereira.   

Abstract

Human cytomegalovirus (HCMV) glycoprotein B (gB) promotes virion entry into cells by fusing the virion envelope with the cellular membrane. We recently reported that UB cells (U373 glioblastoma cells constructed to produce HCMV gB constitutively) form multinucleate syncytia that are dependent on the density of gB in the plasma membrane. In this report, we describe the properties of a clonal cell line, UB31-B3, that expressed a spontaneously mutated form of gB which lacked the fusion-inducing function of the wild-type molecule, and three UB cell lines that were constructed to investigate the effect of specific mutations in gB on syncytium formation. Flow cytometry analysis with a pool of monoclonal antibodies (mAbs) showed that the UB cells contained a high density of gB, which was associated with the cell surface. Immune precipitation experiments with UB31-B3 cells showed that the mutant gB reacted with all of the mAbs to the ectodomain of gB but with none of those to the cytoplasmic carboxy terminus, and that it was 35 kDa smaller than wild-type gB. Nucleotide sequence analysis showed that a termination codon had been introduced after amino acid lysine at position 669 in the ectodomain of UB31-B3 gB, generating a truncated glycoprotein. UB31-B3 gB was not secreted into the medium and was stably anchored in the plasma membrane, which suggested that a hydrophobic stretch of amino acids from 629 to 652 in the ectodomain may serve as a membrane anchor for this truncated form. Analysis of the UB cell lines expressing deleted forms of gB showed that deletion of all or part of the cytoplasmic and transmembrane domains reduced or abolished syncytium formation. In contrast, deletion of a major neutralizing region in the ectodomain of gB did not alter syncytium formation. Results of these studies indicate that different regions of the gB molecule participate in syncytium formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778290     DOI: 10.1006/viro.1995.1290

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.

Authors:  S Tugizov; E Maidji; J Xiao; L Pereira
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.

Authors:  V Gerdts; J Beyer; B Lomniczi; T C Mettenleiter
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress.

Authors:  Thomas C Heineman; Susan L Hall
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.

Authors:  S Tugizov; E Maidji; J Xiao; Z Zheng; L Pereira
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB.

Authors:  N Norais; J A Hall; L Gross; D Tang; S Kaur; S H Chamberlain; R L Burke; F Marcus
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

Authors:  J Singh; T Compton
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 8.  Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.

Authors:  Stephan J Wu; Daniel O Villarreal; Devon J Shedlock; David B Weiner
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

9.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

10.  Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.

Authors:  Thomas R Jones; Shi-Wu Lee; Stephen V Johann; Vladimir Razinkov; Robert J Visalli; Boris Feld; Jonathan D Bloom; John O'Connell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.